Significance of CXCR3 expression in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type for predicting responsiveness to Helicobacter pylori eradication

Cancer Science

Volumn 99, Issue 9, 2008, Pages 1769-1773

  Yamamoto, Hideko ^a,c   Nakamura, Tsuneya ^b   Matsuo, Keitaro ^b   Tajika, Masahiro ^b   Kawai, Hiroki ^b   Ohmiya, Naoki ^c   Niwa, Yasumasa ^c   Goto, Hidemi ^c   Nakamura, Shigeo ^a  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3;

ARTICLE; CANCER GRADING; CANCER REGRESSION; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; ERADICATION THERAPY; FEMALE; GENE EXPRESSION; GENE FUSION; GENE MUTATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOPATHOLOGY; LYMPHOCYTE MIGRATION; MAJOR CLINICAL STUDY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; RISK FACTOR; STOMACH LYMPHOMA; T LYMPHOCYTE ACTIVATION; TREATMENT RESPONSE;

FEMALE; FORECASTING; GENE EXPRESSION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; NEOPLASM STAGING; RECEPTORS, CXCR3; RISK ASSESSMENT; STOMACH NEOPLASMS;

EID: 50149091298     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00883.x     Document Type: Article

References (26)

1. Isaacson PG, Muller-Hermelink HK, Piris MA et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours, Pathology, and Genetics: Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2001; 157-60.
2. Wotherspoon AC, Doglioni C, Diss TC et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-7.
3. Eidt S, Stolte M, Fischer R. Helicobacter pylori gastritis and primary gastric non-Hodgkin's lymphoma. J Clin Pathol 1994; 47: 436-9.
4. Morgner A, Miehlke S, Fischbach W et al. Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection. J Clin Oncol 2001; 19: 2041-8.
5. Raderer M, Isaacson PG. Extranodal lymphoma of MALT-type: Perspective at the beginning of the 21st century. Expert Rev Anticancer Ther 2001; 1: 53-64.
6. Du M-Q, Atherton JC. Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management. Gut 2006; 55: 886-93.
7. Neubauer A, Thiede C, Morgner A et al. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associaated lymphoid tissue lymphoma. J Natl Cancer Inst 1997; 89: 1350-5.
8. Wundisch T, Thiede C, Morgner A et al. Long-term follow-up of MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol 2005; 23: 8018-24.
9. Motegi M, Yonezumi M, Seto M et al. API2-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous products. Am J Pathol 2000; 156: 807-12.
10. Ye H, Liu H, Attygalle A et al. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: Significant association with CagA strains of H. pylori in gastric MALT lymphoma. Blood 2003; 102: 1012-18.
11. Baens M, Maes B, Steyls A et al. The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation. Am J Pathol 2000; 156: 1433-9.
12. Harris NL, Jaffe ES, Diebold J et al. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol 2000; 13: 193-207.
13. Akagi T, Motegi M, Tamura A et al. A novel gene, MALT1 at 18q21, is involved in t(11;18)(q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene 1999; 18: 5785-94.
14. Dierlamm J, Baens M, Wlodarska I et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 1999; 93: 3601-9.
15. Morgan JA, Yin Y, Borowsky AD et al. Breakpoint of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18. Cancer Res 1999; 59: 6205-13.
16. Nakamura T, Nakamura S, Masao S et al. Clinicopathologic comparison between the API2-MALT1 chimeric transcript-positive and -negative gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type. Jpn J Cancer Res 2002; 93: 677-84.
17. Inagaki H, Nakamura T, Nakamura S et al. Gastric MALT lymphoma are divided into three groups based on responsiveness to Helicobacter pylori eradication and detection of API2-MALT1 fusion. Am J Surg Pathol 2004; 28: 1560-7.
18. Liu H, Ruskone-Fourmestraux A, Slove AL et al. Resistance of t(11;18)-positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 2001; 357: 39-40.
19. Liu H, Ye H, Ruskone-Fourmestraux A et al. t(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002; 122: 1286-94.
20. Rollins BJ. Chemokines. Blood 1997; 90: 909-28.
21. Jones D, Benjamin RJ, Shahsafaei A et al. The chemokine receptor CXCR3 is expressed in a subset of B cell lymphomas and is a marker of B cell chronic lymphocytic leukemia. Blood 2000; 95: 627-32.
22. Ohshima K, Suefuji H, Kikuchi M et al. Expression of chemokine receptor CXCR3 and its ligand, Mig, in gastric and thyroid marginal zone lymphomas: Possible migration and autocrine mechanism. Leukemia Lymphoma 2003; 44: 329-36.
23. Suefuji H, Ohshima K, Kikuchi M et al. CXCR3-poitive B cells found at elevated frequency in the peripheral blood of patients with MALT lymphoma are attracted by MIG and belong to lymphoma clone. Int J Cancer 2005; 114: 896-901.
24. Inagaki H, Okabe M, Seto M et al. API2-MALT1 fusion transcripts involved in mucosa-associated lymphoid tissue lymphoma: Multiplex RT-PCR detection using formalin-fixed paraffin-embedded specimens. Am J Pathol 2001; 158: 699-706.
25. de Jong D, Boot H, van Heerde P et al. Histological grading in gastric lymphoma: Pretreatment criteria and clinical relevance. Gastroenterology 1997; 112: 1466-74.
26. Rohatiner A, d'Amore F, Coiffier B et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994; 5: 397-400.